Potential clients would like to do real cancer prevention through analyses and related interventions that can prevent the development of the disease and not discover it when it is already present, as is the case with early detection. The clients themselves are not motivated to undergo genetic tests that indicate any hereditary conditions (through the analysis of germline mutations) that induce a passive position towards the potential development of the disease because they are not modifiable and are mainly a source of stress.
Potential clients, therefore, would like to prevent cancer with an active attitude through the control and management of physiological and modifiable conditions that promote the development of cancer before the disease is formed. Countless interventions can be made to treat physiological conditions that, if altered, are drivers of tumour development. Still, far fewer interventions can be made once the tumour has already formed.
In addition to the limitations highlighted by traditional prevention, which prevents death from cancer rather than cancer, potential customers are forced to undergo invasive diagnostic techniques like colon cancer.